First Participant Vaccinated in Bundibugyo Virus Vaccine Trial in DRC
Audio narration · Coming soon
The first participant has been vaccinated in a key clinical trial testing vaccine candidates against the Bundibugyo virus in the Democratic Republic of Congo. This marks the beginning of a pivotal study aimed at evaluating potential vaccines for this virus.
Why this matters
PRISM scored this story 55/100 for interest.
Originally published by gnews